Scientists argue for more FDA oversight of health care AI tools

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical technologies. That is the takeaway from a new report issued to the FDA, published this week in the open-access journal PLOS Digital Health by Leo Celi of the Massachusetts Institute of Technology and colleagues.
Read More

Scientists argue for more FDA oversight of health care AI tools

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical technologies. That is the takeaway from a new report issued to the FDA, published this week in the open-access journal PLOS Digital Health by Leo Celi of the Massachusetts Institute of Technology and colleagues.
Read More
Top